HEALTHCARE SECURITY FORUM: A HIMSS EVENT
Boston, MA - September 11 - 13, 2017
Suzanne B. Schwartz, MD, MBA is the associate director for Science and Strategic Partnerships in the Center for Devices and Radiological Health (CDRH) at the FDA.
Suzanne’s programmatic efforts in medical device cybersecurity extend beyond incident response to include increasing awareness, educating, outreach, partnering and coalition-building within the Healthcare and Public Health Sector (HPH) as well as fostering collaborations across other parts of government and the private sector.
Suzanne chairs the CDRH Cybersecurity Working Group which is tasked with formulating policy on medical device cybersecurity on behalf of the Agency. She also serves as co-chair of the Government Coordinating Council (GCC) for the HPH Critical Infrastructure Sector, focusing on the sector’s healthcare cybersecurity initiatives.
Suzanne earned an MD from Albert Einstein College of Medicine of Yeshiva University in New York in 1988, trained in General Surgery and Burn Trauma at the New York Presbyterian Hospital - Weill Cornell Medical Center; an executive MBA from NYU Stern School of Business in 2012, and completed Cohort X of the National Preparedness Leadership Initiative – Harvard School of Public Health & Harvard Kennedy School of Government executive education in June 2013.
Medical device cybersecurity is evolving. Multiple community efforts are tackling the challenges facing secure clinical device operation, but unabating attacks and greater device network connectivity mean continued vigilance and agility are needed.
This session will characterize the evolving ecosystem, re-assess gaps and challenges, and outline current and emerging steps the FDA recommends manufacturers take to remain vigilant and continually address the cyber risks of marketed medical devices.
Additionally, attendees will also learn why it is so important for healthcare providers to apply NIST principles (identify, protect, detect, respond, and recover) to navigate the uncharted territory of evolving medical device risks.